All News

The American Academy of Dermatology (AAD) 2023 Annual Meeting took place last month in New Orleans, Louisiana, and The American Journal of Managed Care® was there to cover the latest news—catch up on what you may have missed.

A study including data from more than 2 million patients highlights gender, health insurance, and income disparities in patients receiving extracorporeal membrane oxygenation (ECMO) while hospitalized for severe respiratory illness.

Symptoms of sleep disturbance are associated with an increased risk of stroke and might indicate higher individual risk or be representative of independent risk factors.

This study investigated potential benefits of a virtual education intervention for atopic dermatitis that targeted Hispanic Americans and Spanish-speaking populations.

Research showed that HIV incidence and mortality rates were highest among transgender women who were Black or Latinx or lived in the southern United States.

Rates of asthma diagnoses declined at the beginning at the pandemic compared with rates of new diagnoses in the previous 3 years, according to one study.

The FDA has granted accelerated approval to enfortumab vedotin-ejfv plus pembrolizumab for patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin-containing chemotherapy.

Patients who underwent sublobar resection and those who underwent more invasive lobectomy for early-stage non–small cell lung cancer (NSCLC) showed similar overall and disease-free survival outcomes in a recent study.

Johnson & Johnson designated over $8.9 billion to settle talcum powder lawsuits; a new report from the World Health Organization says that 1 in 6 adults globally are affected by infertility; a new study looks beyond the body mass index of pregnant mothers to identify risk factors for their children being obese.

A new study has found that respiratory syncytial virus (RSV) infections were more frequent and severe compared with influenza A/B in older adults.

Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer at RWJBarnabas Health, discusses key strategies for health systems working to identify and address health disparities.

Treatment with relugolix and concomitant therapies for prostate cancer showed similar safety and efficacy to relugolix alone in a recent study.

Banner|Aetna has partnered with Virta and their diabetes reversal program, which now has data on outcomes and patient populations served so far.

Utilization of telehealth increased by 7% nationally in the first month of 2023.

A ruling by District Judge Reed O’Connor on March 30 called the future of preventive care access into question.

The National Cancer Plan is being implemented as part of the Cancer Moonshot aims; inflation and higher spending are driving up monthly plan premiums under the Affordable Care Act; millions of people may lose Medicaid coverage after pandemic protections end.

The impaired reactivity may play a role in organ injury, the authors suggested, among patients who have immune-mediated thrombotic thrombocytopenic purpura (iTTP).

Data from the PANORAMA-HF and PARADIGM-HF trials support the recommendation for approval from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.

The new research could help identify ways to preserve neuromuscular junctions.

Abdominal and general obesity were associated with adverse respiratory symptoms, with some independent factors identified in women, but not in men.

Use of telehealth-delivered, live coaching of caregiver-child interactions led to improved management of behavioral challenges and increased compliance with caregiver direction.

Patients with myelofibrosis (MF) with single-hit mutations had similar outcomes to patients with wild-type TP53.

Pollen may contribute to an increased risk of asthma attacks and asthma-related emergency visits, according to one study.

Treatment for age-related macular degeneration (AMD) and diabetic macular edema (DME) for a single year was found to be lowest when using bevacizumab.

Rates for reimbursement cuts will be lower than expected within Medicare Advantage plans; financial safety nets, in the form of Social Security and Medicare, are likely to be unable pay full benefits; CDC teams experience symptoms similar to East Palestine, Ohio, residents following train derailment

In this interview from the Association of Community Cancer Centers (ACCC) 2023 Annual Meeting and Cancer Center Business Summit, Olalekan Ajayi, PharmD, MBA, ACCC president, addresses the use of artificial intelligence (AI) in health care equity and why data integrity is just as important as the models used with the data.

Jessica Allegretti, MD, MPH, medical director of the Crohn's and Colitis Center, Brigham and Women's Hospital, speaks on current indications for Rebyota (fecal microbiota, live-jslm) in the treatment of recurrent Clostridioides difficile infection (CDI), as well as coverage and access-related implications for the drug.

Anne Marie Morse, DO, a pediatric neurologist and sleep medicine specialist at Geisinger Medical Center, talked about the challenges that adolescents with narcolepsy face in their social relationships.